Evofem Biosciences

Read more
Saundra Pelletier's photo - CEO of Evofem Biosciences

CEO

Saundra Pelletier

CEO Approval Rating

100/100

Founded:

2009

Status:

PublicIndependent CompanyNASDAQEVFM

EVOFEM BIOSCIENCES TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Evofem Biosciences's company profile
Saundra Pelletier's photo - CEO of Evofem Biosciences

Saundra Pelletier

CEO

100/100
30
$259.3M
$3.4M
View Profile
1
Evofem Biosciences's Competitor - Allergan logo
CEO Avatar

CEO

- -
16,900
$31.1M
$16B
View Profile
2
Evofem Biosciences's Competitor - CooperSurgical logo
Holly Sheffield's photo - President of CooperSurgical

Holly Sheffield

President

89/100
2,300
- -
$680.5M
View Profile
3
Evofem Biosciences's Competitor - Merck logo
Robert M. Davis's photo - CEO of Merck

Robert M. Davis

CEO

89/100
69,000
- -
$50.1B
View Profile
4
Evofem Biosciences's Competitor - TherapeuticsMD logo
Robert G. Finizio's photo - Co-Founder & CEO of TherapeuticsMD

Robert G. Finizio

Co-Founder & CEO

90/100
241
$522.6M
$84.8M
View Profile
5
Evofem Biosciences's Competitor - Agile Therapeutics logo
Alfred Altomari's photo - Chairman & CEO of Agile Therapeutics

Alfred Altomari

Chairman & CEO

90/100
13
$271.5M
$4.7M
View Profile
6
Evofem Biosciences's Competitor - ASCEND Therapeutics logo
Nicholas Hart's photo - President & CEO of ASCEND Therapeutics

Nicholas Hart

President & CEO

82/100
50
- -
$14M
View Profile
7
Evofem Biosciences's Competitor - Celmatix logo
Piraye Yurttas Beim's photo - Founder & CEO of Celmatix

Piraye Yurttas Beim

Founder & CEO

70/100
76
$20.4M
$22M
View Profile
8
Evofem Biosciences's Competitor - ObsEva logo
Brian O’Callaghan's photo - CEO of ObsEva

Brian O’Callaghan

CEO

85/100
45
$326.3M
$ < 1M
View Profile
9
Evofem Biosciences's Competitor - PregLem S.A. logo
Ksenija Pavletic Aranicki's photo - CEO of PregLem S.A.

Ksenija Pavletic Aranicki

CEO

84/100
40
$59.9M
$15.7M
View Profile
10
Evofem Biosciences's Competitor - Progyny logo
David Schlanger's photo - CEO of Progyny

David Schlanger

CEO

82/100
210
$213.1M
$450M
View Profile
11
Evofem Biosciences's Competitor - rEVO Biologics logo
Yann Echelard's photo - CEO of rEVO Biologics

Yann Echelard

CEO

69/100
18
- -
$33.1M
View Profile
12
Evofem Biosciences's Competitor - Duchesnay Inc. logo
CEO Avatar

Dean Hopkins

General Manager

- -
100
- -
$21M
View Profile

Missing a competitor? Contribute!

Allergan is one of Evofem Biosciences's top competitors. Allergan was founded in 1948 in Coolock, County Dublin. Like Evofem Biosciences, Allergan also operates in the Pharmaceuticals industry. Allergan generates $16B more revenue than Evofem Biosciences.

CooperSurgical is a top competitor of Evofem Biosciences. CooperSurgical was founded in 1990, and is headquartered in Trumbull, Connecticut. Like Evofem Biosciences, CooperSurgical also competes in the Pharmaceuticals field. CooperSurgical generates $677.1M more revenue vs. Evofem Biosciences.

Merck is seen as one of Evofem Biosciences's top competitors. Merck is headquartered in Kenilworth, New Jersey, and was founded in 1891. Like Evofem Biosciences, Merck also operates in the Pharmaceuticals field. Merck generates 1,424,501% the revenue of Evofem Biosciences.

Evofem Biosciences Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$3.4M

Evofem Biosciences's revenue is the ranked 17th among it's top 10 competitors. The top 10 competitors average 3.9B. Over the last four quarters, Evofem Biosciences's revenue has grown by 568%. Specifically, in Q2 2021's revenue was $1.9M; in Q1 2021, it was $1.1M; in Q4 2020, it was $ < 1M; in Q3 2020, Evofem Biosciences's revenue was $ < 1M.

Evofem Biosciences Acquisitions

No recent acquisitions found related to Evofem Biosciences

Evofem Biosciences Funding History

Since Evofem Biosciences was founded in 2009, it has participated in 11 rounds of funding. In total Evofem Biosciences has raised $259.3M. Evofem Biosciences' last funding round was on Oct 2021 for a total of $10.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series B
Oct 2021
$10M
Post-IPO Equity
May 2021
$50M
-
Debt
Oct 2020
$25M
Convertible Note
Apr 2020
$15M
-
Private Placement
Jun 2019
$50M

Since Evofem Biosciences was founded in 2009, it has participated in 11 rounds of funding. In total Evofem Biosciences has raised $259.3M. Evofem Biosciences' last funding round was on Oct 2021 for a total of $10.0M

Evofem Biosciences Investments

No recent investments found related to Evofem Biosciences

Evofem Biosciences News

September 27, 2021MarketScreener

Announces Publication in Peer-Reviewed Journal Advances in Therapy

(marketscreener.com) SAN DIEGO, Sept. 27, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., today announ... See more »
September 13, 2021FiercePharma

'Schitt's Creek' actress stars in bold Evofem DTC campaign for Phexxi birth control

'Schitt's Creek' actress stars in bold Evofem DTC campaign for Phexxi birth control bbulik Sun, 09/12... See more »
July 28, 2021BioSpace

Evofem Biosciences to Report Second Quarter 2021 Results and Provide Corporate Update on Wednesday, August 11, 2021

Evofem Biosciences, Inc., (NASDAQ: EVFM) will hold a webcast and conference call to discuss financial... See more »

Evofem Biosciences Press Releases

September 9, 2021LD Micro

Emmy Award Winner Annie Murphy Partners with Evofem Biosciences to Talk Sex, Contraception, and Why She Chose Phexxi

Read this press release and other recent news about Evofem Biosciences Inc. (EVFM) at ldmicro.com... See more »
July 14, 2021PR Newswire

Early Look at Second Quarter Metrics for Phexxi Reveals Strong Growth

SAN DIEGO, July 14, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today provided a pr... See more »
May 25, 2021PR Newswire

Evofem Biosciences to Present at LD Micro Invitational XI on Tuesday, June 8, 2021

/PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that its CEO Saundra Pelleti... See more »
April 28, 2021StreetInsider

Evofem Biosciences Announces Presentation of Two New Phexxi Data Sets at the 2021 American College of Obstetricians and Gynecologists Annual Meeting

SAN DIEGO, April 28, 2021 /PRNewswire/ --Â Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced t... See more »
April 22, 2021PR Newswire

Evofem Biosciences to Report First Quarter 2021 Results and Provide Corporate Update on Thursday, May 6, 2021

/PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) will hold a webcast and conference call to d... See more »
April 21, 2021PR Newswire

Evofem Biosciences to Deliver Keynote Address and Present Two Phexxi Data Sets at NCODA 2021 National Spring Forum

SAN DIEGO, April 21, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced th... See more »
March 17, 2021PR Newswire

Evofem Biosciences' DTC Campaign "Get Phexxi" Delivers Strong Initial Impact

SAN DIEGO, March 17, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced th... See more »

Evofem Biosciences Videos

Social Media

Evofem Biosciences Headquarters

12400 High Bluff Drive Suite 600

San Diego, California92130

1-858-550-1900

Driving Directions »

Trending Companies

Evofem Biosciences Summary

ABOUT

Overview

Evofem is a California-based biopharmaceutical company that develops and commercializes contraceptive products for the treatment of reproductive disorders in women. Evofem Biosciences was founded in 2009. Evofem Biosciences' headquarters is located in...

CEO

Evofem Biosciences's CEO, Saundra Pelletier, currently has an approval rating of 100%. Evofem Biosciences's primary competitors are Allergan, CooperSurgical & Merck.

Website

evofem.com

Frequently Asked Questions about Evofem Biosciences

  1. When was Evofem Biosciences founded?

    Evofem Biosciences was founded in 2009
  2. Who is Evofem Biosciences's CEO?

    Evofem Biosciences's CEO is Saundra Pelletier
  3. How much revenue does Evofem Biosciences generate?

    Evofem Biosciences generates $3.4M in revenue
  4. How much funding does Evofem Biosciences have?

    Evofem Biosciences has historically raised $259.3M in funding
  1. Where is Evofem Biosciences's headquarters?

    Evofem Biosciences's headquarters is in San Diego California, USA
  2. How many employees does Evofem Biosciences have?

    Evofem Biosciences has 30 employees
  3. What sector does Evofem Biosciences operate in?

    Evofem Biosciences is in Biotechnology, Pharmaceuticals
  4. Who are Evofem Biosciences's competitors?

    Evofem Biosciences's top competitors are Allergan, CooperSurgical, Merck